R&D Blueprint
The R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of research and development activities during epidemics. Its aim is to fast-track the availability of effective tests, vaccines and medicines that can be used to save lives and avert large scale crises.
Key actions by disease
News
All →Related activities
Documents
All →
31 March 2026
Paramyxovirus research and development roadmap
The Paramyxoviridae research and development (R&D) roadmap outlines a coordinated global strategy to strengthen preparedness against existing and emerging...
12 March 2026
Arenaviridae research and development roadmap
This roadmap sets out priority research and development actions to accelerate the availability of diagnostics, therapeutics and vaccines for arenaviruses,...
3 March 2026
Filovirus research and development roadmap
In recent decades, the global epidemiological landscape has been marked by an increasing frequency and geographic spread of infectious disease outbreaks....
16 January 2026
Rift Valley fever CORE protocol
Rift Valley fever (RVF) is a zoonotic viral disease caused by Rift Valley fever virus (RVFV). The virus is transmitted to humans through contact with infected...